NSE BSE
orchid pharma limited stock

ORCHID PHARMA LIMITED Share Price

- - (%)
Sector: -

926

524372

ORCHPHARMA

img img img img
No Data Available

ORCHID PHARMA LIMITED Share Price Update


As of the latest trading session, ORCHID PHARMA LIMITED share price is currently at 1078, which is down by -15.44 from its previous closing. Today, the stock has fluctuated between 1068.45 and 1099.00. Over the past year, ORCHID PHARMA LIMITED has achieved a return of 151.10 %. In the last month alone, the return has been 2.07 %.

ORCHID PHARMA LIMITED Performance

Day Range

Low1068.45 High1099.00
1075.10

52 Week Range

Low 395.10 High 1359.95
1075.10

Open Price

1093.45

Prev. Close

1093.45

Volume (Shares)

8135.00

Total traded value

87.45

Upper Circuit

1148.10

Lower Circuit

1038.80

Note: The current prices & values are delayed, Login to your account for live updates.

ORCHID PHARMA LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 4400.00
PE Ratio (TTM) 43.74
Book Value / Share 227.45
Beta 0.66
ROE 0.81%
EPS (TTM) 17.41
Dividend Yield 0.00%
Net Profit Qtr (Cr) 30.55

ORCHID PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 220.59
Operating Expense 197.48
Net Profit 30.55
Net Profit Margin (%) 13.84
Earnings Per Share (EPS) 6.42
EBITDA 43.36
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 198.76
Operating Expense 186.70
Net Profit 20.24
Net Profit Margin (%) 10.18
Earnings Per Share (EPS) 4.40
EBITDA 31.88
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 182.92
Operating Expense 174.04
Net Profit 10.78
Net Profit Margin (%) 5.89
Earnings Per Share (EPS) 2.64
EBITDA 24.04
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 209.90
Operating Expense 184.91
Net Profit 64.87
Net Profit Margin (%) 30.90
Earnings Per Share (EPS) 15.89
EBITDA 80.62
Effective Tax Rate (%) 0.00
Particulars DEC 2022 (Values in Cr)
Revenue 159.76
Operating Expense 161.96
Net Profit 6.73
Net Profit Margin (%) 4.21
Earnings Per Share (EPS) 1.65
EBITDA 22.59
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 665.90
Operating Expense 669.30
Net Profit 54.19
Net Profit Margin (%) 8.13
Earnings Per Share (EPS) 13.28
EBITDA 142.26
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 556.97
Operating Expense 618.75
Net Profit -4.81
Net Profit Margin (%) -0.86
Earnings Per Share (EPS) -1.18
EBITDA 66.25
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 450.70
Operating Expense 553.03
Net Profit -117.15
Net Profit Margin (%) -25.99
Earnings Per Share (EPS) -28.70
EBITDA 64.37
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 481.21
Operating Expense 593.94
Net Profit -149.84
Net Profit Margin (%) -31.13
Earnings Per Share (EPS) -16.87
EBITDA 33.61
Effective Tax Rate (%) 0.00
Particulars MAR 2019 (Values in Cr)
Revenue 583.65
Operating Expense 726.56
Net Profit -101.05
Net Profit Margin (%) -17.31
Earnings Per Share (EPS) -11.36
EBITDA 29.16
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 151.92
ROE % 0.29
ROCE % 1.47
Total Debt to Total Equity 0.45
EBITDA Margin 15.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 141.81
ROE % 0.06
ROCE % -1.10
Total Debt to Total Equity 0.55
EBITDA Margin 11.27
Particulars MAR 2021 (Values in Cr)
Book Value / Share 143.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.72
EBITDA Margin 9.91
Particulars MAR 2020 (Values in Cr)
Book Value / Share 187.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 61.28
EBITDA Margin -1.43
Particulars MAR 2019 (Values in Cr)
Book Value / Share -79.14
ROE % -70.32
ROCE % -3.66
Total Debt to Total Equity 0.00
EBITDA Margin 0.85
Particulars MAR 2023 (Values in Cr)
Book Value / Share 162.53
ROE % 0.81
ROCE % 2.34
Total Debt to Total Equity 0.43
EBITDA Margin 15.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 149.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.53
EBITDA Margin 12.06
Particulars MAR 2021 (Values in Cr)
Book Value / Share 150.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.69
EBITDA Margin 9.75
Particulars MAR 2020 (Values in Cr)
Book Value / Share 178.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 88.62
EBITDA Margin -5.34
Particulars MAR 2019 (Values in Cr)
Book Value / Share -84.86
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 1.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 30.62
Total Assets 1225.20
Total Liabilities 1225.20
Total Equity 688.64
Share Outstanding 40816400
Price to Book Ratio 2.37
Return on Assets (%) 3.78
Return on Capital (%) 4.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.06
Total Assets 1110.56
Total Liabilities 1110.56
Total Equity 647.37
Share Outstanding 40816400
Price to Book Ratio 1.90
Return on Assets (%) -0.17
Return on Capital (%) -0.21
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 19.91
Total Assets 1237.25
Total Liabilities 1237.25
Total Equity 652.90
Share Outstanding 40816400
Price to Book Ratio 16.42
Return on Assets (%) -9.41
Return on Capital (%) -10.76
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 174.04
Total Assets 1459.90
Total Liabilities 1459.90
Total Equity 765.98
Share Outstanding 40816400
Price to Book Ratio 0.00
Return on Assets (%) -8.97
Return on Capital (%) -10.32
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 325.51
Total Assets 3077.03
Total Liabilities 3077.03
Total Equity -704.03
Share Outstanding 88964327
Price to Book Ratio -0.06
Return on Assets (%) 2.25
Return on Capital (%) 4.9
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 22.33
Total Assets 1223.25
Total Liabilities 1223.25
Total Equity 731.96
Share Outstanding 40816400
Price to Book Ratio 2.37
Return on Assets (%) 4.42
Return on Capital (%) 5.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.20
Total Assets 1094.18
Total Liabilities 1094.18
Total Equity 677.95
Share Outstanding 40816400
Price to Book Ratio 1.90
Return on Assets (%) -0.43
Return on Capital (%) -0.51
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.96
Total Assets 1224.46
Total Liabilities 1224.46
Total Equity 681.33
Share Outstanding 40816400
Price to Book Ratio 16.42
Return on Assets (%) -9.56
Return on Capital (%) -10.33
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 172.31
Total Assets 1449.99
Total Liabilities 1449.99
Total Equity 797.82
Share Outstanding 40816400
Price to Book Ratio 0.00
Return on Assets (%) -10.33
Return on Capital (%) -11.51
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 324.17
Total Assets 2993.25
Total Liabilities 2993.25
Total Equity -754.99
Share Outstanding 88964327
Price to Book Ratio -0.06
Return on Assets (%) -3.37
Return on Capital (%) -7.4
Particulars MAR 2023 (Values in Cr)
Net Income 46.31
Cash from Operations 18.63
Cash from Investing -31.21
Cash from Financing 31.16
Net change in Cash 18.29
Free Cash Flow 103.54
Particulars MAR 2022 (Values in Cr)
Net Income -1.95
Cash from Operations 94.38
Cash from Investing 112.93
Cash from Financing -216.79
Net change in Cash -11.38
Free Cash Flow 108.78
Particulars MAR 2021 (Values in Cr)
Net Income -116.53
Cash from Operations 18.66
Cash from Investing 67.20
Cash from Financing -164.98
Net change in Cash -74.19
Free Cash Flow 19.26
Particulars MAR 2020 (Values in Cr)
Net Income -131.07
Cash from Operations 70.38
Cash from Investing 167.11
Cash from Financing -250.33
Net change in Cash -2.41
Free Cash Flow 74.62
Particulars MAR 2019 (Values in Cr)
Net Income 69.40
Cash from Operations 16.30
Cash from Investing 45.47
Cash from Financing -0.29
Net change in Cash 57.19
Free Cash Flow 22.92
Particulars MAR 2023 (Values in Cr)
Net Income 54.18
Cash from Operations 13.68
Cash from Investing -26.69
Cash from Financing 31.16
Net change in Cash 17.85
Free Cash Flow 98.24
Particulars MAR 2022 (Values in Cr)
Net Income -4.80
Cash from Operations 91.47
Cash from Investing 112.93
Cash from Financing -216.79
Net change in Cash -14.30
Free Cash Flow 105.87
Particulars MAR 2021 (Values in Cr)
Net Income -117.15
Cash from Operations 19.44
Cash from Investing 67.20
Cash from Financing -164.98
Net change in Cash -73.42
Free Cash Flow 20.04
Particulars MAR 2020 (Values in Cr)
Net Income -149.83
Cash from Operations 69.99
Cash from Investing 167.11
Cash from Financing -250.33
Net change in Cash -2.79
Free Cash Flow 74.23
Particulars MAR 2019 (Values in Cr)
Net Income -101.05
Cash from Operations 19.46
Cash from Investing 45.47
Cash from Financing -0.29
Net change in Cash 60.36
Free Cash Flow 26.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
ORCHID PHARMA LIMITED 1090.55 64.80 4.99 5531.17 404.05 / 1358.80
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
ORCHID PHARMA LIMITED 1090.55 62.64 4.79 5531.17 404.05 / 1358.80
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1070.40
  • 26 Days 1068.70
  • 10 Days 1054.80
  • 50 Days 1079.80
  • 12 Days 1057.10
  • 100 Days 983.30
  • 20 Days 1056.20
  • 200 Days 612.50
1087.53
PIVOT
First Resistance 1103.37
Second Resistance 1113.28
Third Resistance 1129.12
First Support 1077.62
Second Support 1061.78
Third Support 1051.87
RSI 51.54
MACD -11.59
Commodity Channel Index (CCI) 83.46
ADX 20.34
Williams % R -14.07

Over 1 Month

down

2.07

Over 3 Months

down

-1.22

Over 6 Months

down

108.65

Over 1 Year

down

151.10

Over 3 Years

down

-8.71

Over 5 Years

down

200.66

ORCHID PHARMA LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ORCHID PHARMA LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
13.02
Promoter Holdings
69.83
FII
1.96
DII
15.17
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Dhanuka Laboratories Limited Shareholding of Promoter and Promoter Group 3.5419957E7 69.84
Quant Mutual Fund-quant Value Fund, Quant Multi Asset Fund, Quant Small Cap Fund Public Shareholding 3465947.0 6.83
Invesco India Contra Fund & Invesco India Smallcap Fund Along With Other 4 Names Public Shareholding 2011130.0 3.97
Nippon Life India Trustee Ltd-a/c Nippon India Pharma Fund Public Shareholding 723032.0 1.43
Carnelian Structural Shift Fund Public Shareholding 618919.0 1.22

ORCHID PHARMA LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2012-09-13 3.0 Final 2012-09-15 Equity shares 2011-07-19 3.0 Final 2011-07-21 Equity shares 2010-07-12 10.0 Final 2010-07-14 Equity shares 2009-09-17 1.0 Final 2009-09-19 Equity shares 2008-09-18 3.0 Final 2008-09-20 Equity shares 2007-07-12 3.0 Final 2007-07-15 Equity shares 2006-05-30 0.0 Final 2006-06-01 Equity shares 2005-07-13 0.0 Interim 2005-07-15 Equity shares
Ex-Date Ex-Bonus Ratio
2005-09-17 2005-09-15 1:2
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ORCHID PHARMA LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ORCHID PHARMA LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Orchid Pharma Ltd?

Answer Field

The share price of Orchid Pharma Ltd for NSE is ₹ 1078 and for BSE is ₹ 1093.3.

What is the Market Cap of Orchid Pharma Ltd?

Answer Field

The market cap of Orchid Pharma Ltd for NSE is ₹ 4,400.00 Cr. and for BSE is ₹ 4,462.45 Cr. as of now.

What is the 52 Week High and Low of Orchid Pharma Ltd?

Answer Field

The 52 Week High and Low of Orchid Pharma Ltd for NSE is ₹ 1359.95 and ₹ 395.10 and for BSE is ₹ 1358.80 and ₹ 404.05.

How to Buy Orchid Pharma Ltd share?

Answer Field

You can trade in Orchid Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Orchid Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 151.10%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader